NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP
AtriCure, Inc. ATRC
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$534.5M
▲ 14.9% vs FY2024
EPS · FY25
$-0.24
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-2.4%
Net margin · FY25
-2.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 534.5M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 2 cents on every revenue dollar this year.
Per share
USD -0.24
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-2.4%
Return on equity, FY2025
ROE
Operating margin-1.8%
Net margin-2.1%
Return on assets-1.8%
Each USD of equity lost 2 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+20.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+17.4%
+20.9%
+15.2%
+15.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.05B
Shares outstanding, FY2025
Change, 5 years+9.8%
Change, 10 years+54.3%
The share count grew 10% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 654.2M
total assets, end of FY2025
Total assetsUSD 654.2M
EquityUSD 491.9M
CashUSD 167.4M
Gross debtUSD 61.9M
Net debtUSD -105.6M
Current ratio3.96×
The company holds more cash than debt.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.5
0.5
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Operating income $B
−0.0
−0.0
−0.0
−0.0
0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
0.0
−0.0
−0.0
−0.0
0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.24
−0.95
−0.66
−1.02
1.09
−1.14
−0.94
−0.62
−0.83
−1.05
−0.97
−0.61
−0.56
−0.47
−0.35
−0.25
−1.13
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−2.4
−9.6
−6.6
−9.9
11.2
−14.6
−14.2
−10.3
−16.3
−18.8
−17.0
−15.8
−26.9
−53.6
−33.7
−22.4
−96.5
Shares out B
0.05
0.05
0.05
0.05
0.05
0.05
0.04
0.04
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
65 of 65
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed